Pediatric supraglottic airway devices in clinical practice: A prospective observational study
| Autor: | Malte Book, Robert Greif, Lorenz Theiler, Anne Gottfried, Sabine Nabecker, M. Kleine-Brueggeney |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2017 |
| Předmět: |
Male
medicine.medical_specialty Leak medicine.medical_treatment General anesthesia Airway management 610 Medicine & health Laryngeal Masks lcsh:RD78.3-87.3 03 medical and health sciences 0302 clinical medicine Insertion time Laryngeal mask airway 030202 anesthesiology Anesthesiology Supraglottic airway device medicine Intubation Intratracheal Humans Pediatric anesthesia Prospective Studies Elective surgery Adverse effect Child business.industry 030208 emergency & critical care medicine Supraglottitis respiratory system Surgery Anesthesiology and Pain Medicine lcsh:Anesthesiology Anesthesia Child Preschool Female Airway business Research Article |
| Zdroj: | Kleine-Brüggeney, Maren; Gottfried, Anne; Nabecker, Sabine; Greif, Robert; Book, Malte; Theiler, Lorenz (2017). Pediatric supraglottic airway devices in clinical practice: A prospective observational study. BMC anesthesiology, 17(1), p. 119. BioMed Central 10.1186/s12871-017-0403-6 BMC Anesthesiology, Vol 17, Iss 1, Pp 1-8 (2017) BMC Anesthesiology |
| DOI: | 10.1186/s12871-017-0403-6 |
| Popis: | Supraglottic airway devices (SGA) are commonly used in pediatric anesthesia and serve as primary or back-up devices for difficult airway management. Most SGA are marketed without proper clinical evaluation. The purpose of this study was to evaluate the performance of the pediatric LMA Supreme™, Air-Q® and Ambu® Aura-i™. This prospective observational study was performed at Bern University Hospital, Switzerland. With ethics committee approval and a waiver for written informed consent 240 children undergoing elective surgery with an ASA class I-III and a weight of 5-30 kg were included. Three different pediatric supraglottic airway devices were assessed: The LMA Supreme™, Air-Q® and Ambu® Aura-i™. Primary outcome parameter was airway leak pressure. Secondary outcome parameters included first attempt and overall success rate, insertion time, fiberoptic view through the SGA, and adverse events. The primary hypothesis was that the mean airway leak pressure of each tested SGA was 20 cmH2O ± 10%. None of the SGA showed a mean airway leak pressure of 20 cmH2O ± 10%, but mean airway leak pressures differed significantly between devices [LMA Supreme™ 18.0 (3.4) cmH2O, Air-Q® 15.9 (3.2) cmH2O, Ambu® Aura-i™ 17.3 (3.7) cmH2O, p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|